accaccordingacuteadministrationadultsadverseahaamericanamonganalysisantiplateletaorticapixabanarterialarteryaspirinassociatedassociationatheroscleroticatrialbasedbenefitsbetableedingblockerblockersbloodbypasscardiaccardiogeniccardiomyopathycardiovascularcarotidcenterchronicclinicalclopidogrelcohortcombinationcombinedcomparedcomparisoncongresscontemporarycontrolcontrolledcoronarycriticallydaptdatadiabetesdirecteddiseasedrugdualearlyeffecteffectivenesseffectsefficacyejectionelevationendovascularesceventsfactorsfailurefibrillationflowfollowingfractionfunctiongraftingguidelineguidelineshbrhearthfhfpefhfrefhighhighlightshospitalhypertensionhypertrophicillimpactimprovesincidenceindividualinfarctinfarctioninhibitorinhibitorsinitiationinjuryinsightsinterventionischemickeyleftlevellongmajormanagementmedicalmellitusmetametoprololmildlymitralmoderatemonotherapymonthmortalitymulticentermyocardialnationwideobstructiveocclusiononsetoraloutcomesp2y12patientpatientspatternspcipediatricpercutaneousperipheralpharmacologicalplateletpluspointspostpotentpreservedpressurepreventionprimaryprognosticpulmonaryrandomisedrandomizedrapidraterealreceptorreducedreductionregistryregurgitationremodelingrepairreperfusionresultsretrospectiverevascularizationreviewriskrivaroxabansafetysecondarysegmentseveresexsglt2shockshortsizestemistentingstrokestudysyndromesyndromessystematicsystemictermtherapyticagrelortotaltranscathetertreatedtreatmenttreatmentstrialtrialstwilighttypeundergoingusevaluevalveventricularversuswithoutworldyoung